These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12176297)

  • 1. Rifampicin microparticles production by supercritical antisolvent precipitation.
    Reverchon E; De Marco I; Della Porta G
    Int J Pharm; 2002 Aug; 243(1-2):83-91. PubMed ID: 12176297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supercritical antisolvent co-precipitation of rifampicin and ethyl cellulose.
    Djerafi R; Swanepoel A; Crampon C; Kalombo L; Labuschagne P; Badens E; Masmoudi Y
    Eur J Pharm Sci; 2017 May; 102():161-171. PubMed ID: 28302396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supercritical antisolvent precipitation of PHBV microparticles.
    Costa MS; Duarte AR; Cardoso MM; Duarte CM
    Int J Pharm; 2007 Jan; 328(1):72-7. PubMed ID: 16971075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terbutaline microparticles suitable for aerosol delivery produced by supercritical assisted atomization.
    Reverchon E; Della Porta G
    Int J Pharm; 2003 Jun; 258(1-2):1-9. PubMed ID: 12753748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of inhalable rifampicin-poly(L-lactide) microparticles by supercritical anti-solvent process.
    Patomchaiviwat V; Paeratakul O; Kulvanich P
    AAPS PharmSciTech; 2008; 9(4):1119-29. PubMed ID: 18989787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of cromolyn sodium microparticles for aerosol delivery by supercritical assisted atomization.
    Reverchon E; Adami R; Caputo G
    AAPS PharmSciTech; 2007 Dec; 8(4):E114. PubMed ID: 18181535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of sustained release rifampicin microparticles for inhalation.
    Son YJ; McConville JT
    J Pharm Pharmacol; 2012 Sep; 64(9):1291-302. PubMed ID: 22881441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of solvent type on the nanoparticle formation of atorvastatin calcium by the supercritical antisolvent process.
    Kim MS; Song HS; Park HJ; Hwang SJ
    Chem Pharm Bull (Tokyo); 2012; 60(4):543-7. PubMed ID: 22466739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of ethyl cellulose/methyl cellulose blends by supercritical antisolvent precipitation.
    Duarte AR; Gordillo MD; Cardoso MM; Simplício AL; Duarte CM
    Int J Pharm; 2006 Mar; 311(1-2):50-4. PubMed ID: 16423476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microencapsulation of antibiotic rifampicin in poly(3-hydroxybutyrate-co-3-hydroxyvalerate).
    Durán N; Alvarenga MA; Da Silva EC; Melo PS; Marcato PD
    Arch Pharm Res; 2008 Nov; 31(11):1509-16. PubMed ID: 19023549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
    Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
    Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z
    Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
    Pai RV; Jain RR; Bannalikar AS; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the solubility and bioavailability of poorly water-soluble drugs using supercritical antisolvent (SAS) process.
    Abuzar SM; Hyun SM; Kim JH; Park HJ; Kim MS; Park JS; Hwang SJ
    Int J Pharm; 2018 Mar; 538(1-2):1-13. PubMed ID: 29278733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supercritical Antisolvent Precipitation of Corticosteroids/β-Cyclodextrin Inclusion Complexes.
    Mottola S; De Marco I
    Polymers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellulose Acetate and Supercritical Carbon Dioxide: Membranes, Nanoparticles, Microparticles and Nanostructured Filaments.
    Cardea S; De Marco I
    Polymers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of physical-chemical variables affecting particle size following precipitation using a supercritical fluid.
    Sacha GA; Schmitt WJ; Nail SL
    Pharm Dev Technol; 2006; 11(2):195-205. PubMed ID: 16749530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ampicillin micronization by supercritical assisted atomization.
    Reverchon E; Della Porta G; Spada A
    J Pharm Pharmacol; 2003 Nov; 55(11):1465-71. PubMed ID: 14713356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supercritical fluid assisted atomization introduced by an enhanced mixer for micronization of lysozyme: Particle morphology, size and protein stability.
    Du Z; Guan YX; Yao SJ; Zhu ZQ
    Int J Pharm; 2011 Dec; 421(2):258-68. PubMed ID: 22001535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.